How do you finance buying an existing veterinary practice?

Veterinary practice acquisitions have intensified over the last decade as corporate consolidators -- Mars Petcare (Banfield, VCA, BluePearl), National Veterinary Associates (NVA), and Pathway Vet Alliance -- have acquired thousands of independent practices. This consolidation wave has driven practice valuations higher (independent practices now trade at 6--10x EBITDA in many markets) and made SBA-backed acquisition financing the critical tool for individual DVMs competing against institutional buyers who pay cash. The goodwill component -- client relationships, established appointment volume, staff team continuity, and brand recognition -- represents 60--80% of most practice purchase prices. Conventional bank loans won't finance goodwill. SBA 7(a) will.

How veterinary practice cash flow and corporate consolidation affect acquisition loan qualification

SBA underwriters evaluate acquisition transactions on the target practice's trailing 2-year average revenue and EBITDA -- the buyer's DSCR is calculated on the practice's existing income stream plus the incremental revenue the buyer expects to generate. A DVM buyer who can document their production history (revenue generated per doctor per day) at their current employer adds a forward-looking DSCR argument. BLS Quarterly Census of Employment and Wages (QCEW) for NAICS 54194 provides regional employment and payroll benchmarks -- SBA appraisers cross-reference acquisition targets against QCEW data to validate revenue per-employee ratios. Corporate consolidators have created a secondary effect: seller/retiring DVMs who accept corporate offers often receive 7--10x EBITDA in all-cash deals; individual DVM buyers using SBA financing typically need to offer a competitive multiple while structuring a seller carry note to reduce the equity injection requirement -- a seller note can cover up to 50% of the required 10% equity injection (up to 5% of the purchase price).

Acquisition loan mechanics for veterinary practice purchases

The SBA 7(a) program is the primary product for veterinary practice acquisitions. Under 13 CFR Part 121, NAICS 54194 practices qualify up to $10M in average annual receipts. SBA 7(a) will finance: goodwill (client relationships, going-concern value), real property (if part of the transaction), equipment (radiography, surgical, lab), working capital at transition, and covenant-not-to-compete payments to the seller. The typical structure: 10% buyer equity injection (up to 50% of which -- up to 5% of the purchase price -- can come from a seller carry note) and a 90% SBA 7(a) term loan at up to 10-year terms. Under SBA SOP 50 10 8 (effective June 1, 2025), a seller note counted toward the equity injection must be on full standby for the entire life of the SBA loan -- the seller receives no principal or interest until the SBA loan is fully repaid, a tightening from the prior rule that allowed partial standby after 24 months. Seller carry reduces the cash the buyer needs at closing and signals to the SBA that the seller has confidence in the practice's transition success.

SBA program fit for veterinary practice acquisitions

SBA 7(a) is specifically designed for goodwill-inclusive professional practice acquisitions -- it is the dominant product for dental, optometry, veterinary, and physician practice transitions. A key advantage: the SBA's underwriting treats the practice's income-generating capacity as primary collateral, not the liquidation value of hard assets. This means a $1.2M veterinary practice with $200K in equipment (tangible) and $1M in goodwill (intangible) can still finance at 80--90% LTV. For practices that include real estate in the transaction, the SBA 504 program can finance the real estate component separately at long-term fixed rates while SBA 7(a) handles the practice/goodwill portion.

Common qualification thresholds for veterinary practice acquisition loans

• Buyer FICO: 650+ (SBA 7(a) standard); 680+ preferred for large acquisitions ($750K+)
• Equity injection: minimum 10% of purchase price; a seller carry note can satisfy up to 50% of that requirement (up to 5% of purchase price) if placed on full standby for the entire SBA loan term
• DSCR: 1.25x based on target practice trailing 2-year average NOI; buyer production history adds supplemental forward-looking evidence
• License transfer: buyer must hold active state veterinary board licensure in the practice state before SBA closing; DEA registration transfer required within 30 days of ownership change for practices dispensing controlled substances
• Business valuation: independent appraisal required for SBA 7(a) acquisition loans; veterinary practice CPA or certified practice consultant appraisal accepted
• Seller note: capped at 5% of purchase price (50% of the required 10% equity injection); must be on full standby for the entire SBA loan term under SOP 50 10 8, not just 24 months

Veterinary-specific acquisition underwriting concerns

Veterinary acquisition underwriters focus on: DEA registration transfer -- the buyer must notify DEA within 30 days of acquiring a practice that dispenses controlled substances per DEA Diversion Control Division requirements; a gap in DEA coverage is an operational and legal risk; staff retention post-acquisition -- veterinary practices are highly staff-dependent (lead technicians, front desk team); lenders may require employment agreements or retention bonuses to reduce turnover risk at transition; client retention projection -- the buyer's transition plan and communication strategy affect the lender's confidence in revenue continuity; state practice act corporate structure -- the buyer entity must comply with the state's professional corporation or LLC requirements for DVM ownership; and practice real estate -- if the practice leases its facility, lease assignment and landlord consent are required for closing.